Pfizer Acquires Obesity Drugmaker Metsera for $4.9B
Pfizer Acquires Metsera, a Leading Obesity Drug Developer, for $4.9B Pharmaceutical titan Pfizer disclosed on Monday its plans to acquire obesity drug creator Metsera. The deal, valued at an upfront…
